Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in EDIT — Editas Medicine, Inc.

CIK 1423053 MIAMI, FL
Back to EDIT Full portfolio

Position in EDIT

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$689,345
-$946,755 QoQ
Shares Held
212,761
-67.9% QoQ
Ownership
0.139%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 216 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EDIT Over Time

Shares Held

Position Value (USD)

Derivatives in EDIT

reported options exposure · as of Jun 30, 2026
CallValue
$229,392
CallShares
70,800
PutValue
$557,604
PutShares
172,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,739,871 across 435 Biotechnology names. EDIT ranks #258 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in EDIT

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $689,345 212,761
2026-06-30 $229,392 70,800
2026-06-30 $557,604 172,100
2026-03-31 $1,636,100 662,389
2026-03-31 $219,336 88,800
2026-03-31 $307,762 124,600
2025-12-31 $138,580 67,600
2025-12-31 $111,520 54,400
2025-12-31 $1,683,035 820,993
2025-09-30 $1,256,809 362,193
2025-09-30 $328,609 94,700
2025-09-30 $223,121 64,300
2025-06-30 $1,405,153 638,706
2025-06-30 $248,600 113,000
2025-06-30 $126,940 57,700
2025-03-31 $101,384 87,400
2025-03-31 $61,828 53,300
2025-03-31 $135,349 116,681
2024-12-31 $148,336 116,800
2024-12-31 $64,770 51,000
2024-12-31 $1,170,960 922,016
2024-09-30 $229,493 67,300
2024-09-30 $1,190,942 349,250
2024-09-30 $197,780 58,000
2024-06-30 $255,449 54,700
2024-06-30 $1,033,629 221,334
2024-06-30 $605,699 129,700
2024-03-31 $473,396 63,800
2024-03-31 $335,384 45,200
2024-03-31 $5,312,103 715,917
2023-12-31 $9,123,412 900,633
2023-12-31 $1,618,774 159,800
2023-12-31 $909,674 89,800
2023-09-30 $2,850,197 365,410
2023-09-30 $1,036,620 132,900
2023-09-30 $1,372,800 176,000
2023-06-30 $1,456,710 177,000
2023-06-30 $2,757,905 335,104
2023-06-30 $1,818,007 220,900
2023-03-31 $11,765,437 1,622,819
2023-03-31 $1,057,050 145,800
2023-03-31 $1,841,500 254,000
2022-12-31 $1,589,504 179,200
2022-12-31 $7,267,927 819,383
2022-12-31 $2,763,892 311,600
2022-09-30 $10,953,220 894,871
2022-09-30 $2,448,000 200,000
2022-09-30 $4,044,096 330,400
2022-06-30 $14,872,320 1,257,170
2022-06-30 $3,301,753 279,100